Ofrat Beyar‐Katz
- Oncology top 10%
- CAR-T cell therapy research 19
- Neutropenia and Cancer Infections 5
- Hematology top 10%
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 4
- Infectious Diseases top 10%
- Genetics top 10%
- Virus-based gene therapy research 4
- Chronic Lymphocytic Leukemia Research 4
- Blood disorders and treatments 4
-
- Lymphoma Diagnosis and Treatment 6
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Ofrat Beyar‐Katz
38 papers receiving 752 citations
Peers
Comparison fields: 5 of 80
- Oncology 444
- Hematology 136
- Infectious Diseases 180
- Immunology 179
- Genetics 85
Countries citing papers authored by Ofrat Beyar‐Katz
This map shows the geographic impact of Ofrat Beyar‐Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofrat Beyar‐Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofrat Beyar‐Katz more than expected).
Fields of papers citing papers by Ofrat Beyar‐Katz
This network shows the impact of papers produced by Ofrat Beyar‐Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofrat Beyar‐Katz. The network helps show where Ofrat Beyar‐Katz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ofrat Beyar‐Katz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 40 | |
| 11 | 2021 | 94 | |
| 12 | 2019 | 30 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 83 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 43 | |
| 17 | 2016 | 10 | |
| 18 | 2016 | 6 | |
| 19 | 2015 | 23 | |
| 20 | 2014 | 44 |
About Ofrat Beyar‐Katz
Ofrat Beyar‐Katz is a scholar working on Hematology, Oncology and Genetics, having authored 41 papers that have together received 755 indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers), Neutropenia and Cancer Infections (5 papers), Virus-based gene therapy research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Blood disorders and treatments (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Oncology (444 citations), Hematology (136 citations) and Infectious Diseases (180 citations). Ofrat Beyar‐Katz has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Yuval Shaked, Saar Gill, Irit Avivi, Michael Timaner, Chava Perry, Yael Bar‐On, Ron Ram, Odelia Amit, Noam Benyamini and Gabi Shefer. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.